Dexamethasone Treatment Options

A collection of 1455 research studies where Dexamethasone is the interventional treatment. These studies are located in the United States. Dexamethasone is used for conditions such as Multiple Myeloma, Lymphoma and Postoperative Pain.

Home

All Treatments

Dexamethasone

Show Filters

Match to Clinical Trials

Access to cutting-edge treatments

Latest clinical trials

Find trials in your area

Start Matching

Filter by Age

Featured Trial

Paid Clinical Studies Nationwide

Recruiting

Nationwide clinical trials offered in your area. Some trials offering up to several thousand dollars in compensation for participation.

Conditions:

Healthy

Healthy Volunteer Study

Learn More

* Compensation for time may be available

Featured Trial

Chronic Cough Research Study

Recruiting

Are you tired of living with chronic cough? Our research study is now looking to enroll people from all backgrounds to help research potential new treatment options for chronic cough.
You are under no obligation to take part and health insurance is not required. Find out more today! We’d love to hear from you!

Conditions:

Chronic Cough

Refractory or Unexplained Chronic Cough

Cough

Asthma

Sinusitis

Learn More

Featured Offer

Lose Weight with GLP-1 Medications

Recruiting

Policy Lab has partnered with CareGLP to offer trusted access to GLP-1 medications, including generic alternatives to Ozempic® and Wegovy®.

GLP-1 medications are scientifically backed to help individuals achieve significant weight loss—on average, 15-20% of body weight within a year.

As a valued user, you’re eligible for $100 off your first program with code policy-lab-100.

Conditions:

Overweight

Overweight and Obesity

Obesity

Weight Loss

Morbid Obesity

Learn More

A Study Designed to Evaluate the Safety and Efficacy of Venetoclax Plus Dexamethasone (VenDex) Compared With Pomalidomide Plus Dexamethasone (PomDex) in Participants With t(11;14)-Positive Relapsed or Refractory Multiple Myeloma.

NCT03539744

Active Not Recruiting

A study designed tocompare progression-free survival (PFS) in participants with t(11;14)-positive MM treated with venetoclax in combination with dexamethasone versus pomalidomide in combination with dexamethasone.

Gender:

ALL

Ages:

18 years and above

Trial Updated:

06/05/2025

Locations: Duplicate_University of Arizona Cancer Center - North Campus /ID# 218407, Tucson, Arizona +179 locations

Duplicate_University of Arizona Cancer Center - North Campus /ID# 218407, Tucson, Arizona

VA Central California Health Care System /ID# 200047, Fresno, California

University of California, Los Angeles /ID# 171524, Los Angeles, California

Rocky Mountain Regional VA Medical Center/Eastern Colorado Health Care System /ID# 222904, Aurora, Colorado

Mayo Clinic /ID# 200075, Jacksonville, Florida

Cleveland Clinic Florida /ID# 208884, Weston, Florida

Duplicate_Norton Cancer Institute /ID# 200834, Louisville, Kentucky

University of Maryland, Baltimore /ID# 217422, Baltimore, Maryland

Boston Medical Center /ID# 223606, Boston, Massachusetts

Barbara Ann Karmanos Cancer In /ID# 201377, Detroit, Michigan

Duplicate_Henry Ford Hospital /ID# 171531, Detroit, Michigan

Mayo Clinic - Rochester /ID# 201091, Rochester, Minnesota

Columbia University Medical Center /ID# 200715, New York, New York

Fairview Hospital - Moll Pavilion /ID# 208919, Cleveland, Ohio

Cleveland Clinic Main Campus /ID# 202247, Cleveland, Ohio

UPMC Hillman Cancer Ctr /ID# 200063, Pittsburgh, Pennsylvania

MD Anderson Cancer Center at Texas Medical Center /ID# 200060, Houston, Texas

Huntsman Cancer Institute /ID# 218406, Salt Lake City, Utah

VA Puget Sound Health Care System /ID# 222708, Seattle, Washington

Liverpool Hospital /ID# 202431, Liverpool, New South Wales

Sydney Adventist Hospital /ID# 222874, Wahroonga, New South Wales

Wollongong Hospital /ID# 205545, Wollongong, New South Wales

ICON Cancer Care - Townsville /ID# 206565, Hyde Park, Queensland

Icon Cancer Centre /ID# 205663, South Brisbane, Queensland

The Queen Elizabeth Hospital /ID# 202432, Woodville South, South Australia

Perth Blood Institute Ltd /ID# 206649, Nedlands, Western Australia

Arthur J. E. Child Comprehensive Cancer Centre /ID# 218846, Calgary, Alberta

BC Cancer - Vancouver /ID# 222804, Vancouver, British Columbia

QE II Health Sciences Centre /ID# 218883, Halifax, Nova Scotia

CISSS-CA (Centre Integre de sante et de services sociaux de Chaudiere-Appalache) /ID# 218887, Levis, Quebec

Beijing Chaoyang Hospital,Capital Medical University /ID# 216014, Beijing, Beijing

Peking University Third Hospital /ID# 216371, Beijing, Beijing

Peking Union Medical College Hospital (East) - Dongdan Campus /ID# 216040, Beijing, Beijing

Sun Yat-Sen University Cancer Center /ID# 223828, Guangzhou, Guangdong

Guangdong Provincial People's Hospital /ID# 215860, Guangzhou, Guangdong

Henan Cancer Hospital /ID# 215987, Zhengzhou, Henan

Union Hospital Tongji Medical College Huazhong University of Science and Technol /ID# 215850, Wuhan, Hubei

Nanjing Drum Tower Hospital /ID# 223143, Nanjing, Jiangsu

The First Affiliated Hospital of Soochow University /ID# 216094, Suzhou, Jiangsu

The First Affiliated Hospital of Nanchang University /ID# 216954, Nanchang, Jiangxi

The First Hospital of China Medical University /ID# 215996, Shenyang, Liaoning

Shengjing Hospital of China Medical University /ID# 223435, Shenyang, Liaoning

Ruijin Hospital, Shanghai Jiaotong University School of Medicine /ID# 216643, Shanghai, Shanghai

Shanghai Tongji Hospital /ID# 218865, Shanghai, Shanghai

West China Hospital, Sichuan University /ID# 216647, Chengdu, Sichuan

Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sc /ID# 216041, Tianjin, Tianjin

Tianjin Medical University Cancer Institute & Hospital /ID# 223550, Tianjin, Tianjin

The First Affiliated Hospital, Zhejiang University School of Medicine /ID# 215989, Hangzhou, Zhejiang

The First Affiliated Hospital, Zhejiang University School of Medicine /ID# 218691, Hangzhou, Zhejiang

The First Affiliated Hospital of Wenzhou Medical University /ID# 218953, Wenzhou, Zhejiang

Beijing Chaoyang Hospital, Capital Medical University(West campus) /ID# 234033, Beijing, Not set

Fakultní Nemocnice Brno - Jihlavská /ID# 204512, Brno, Brno-mesto

Fakultní nemocnice Hradec Králové - Sokolská /ID# 221291, Hradec Králové, Hradec Kralove

Fakultni Nemocnice Ostrava /ID# 204515, Ostrava, Ostrava-mesto

Fakultni nemocnice Olomouc /ID# 221290, Olomouc, Not set

Vseobecna fakultni nemocnice v Praze /ID# 221166, Praha, Not set

Duplicate_Herlev Hospital /ID# 223221, Herlev, Hovedstaden

Aalborg University Hospital /ID# 223220, Aalborg, Nordjylland

Odense University Hospital /ID# 223217, Odense, Syddanmark

Sygehus Lillebalt, Vejle /ID# 223216, Vejle, Syddanmark

Duplicate_Roskilde Hospital /ID# 223366, Roskilde, Not set

Hopital Pitie Salpetriere /ID# 214173, Paris Cedex 13, Ile-de-France

Duplicate_CHU Grenoble - Hopital Michallon /ID# 223182, La Tronche, Isere

CHU Reims - Hôpital Robert Debre /ID# 233907, Reims CEDEX, Marne

CHRU Nancy - Hopitaux de Brabois /ID# 201076, Vandoeuvre-les-Nancy, Meurthe-et-Moselle

CHRU Lille - Hopital Claude Huriez /ID# 202213, Lille, Nord

Hopitaux Universitaires Henri Mondor - Hopital Henri Mondor /ID# 202211, Creteil, Paris

CHU de Nantes, Hotel Dieu -HME /ID# 200099, Nantes, Pays-de-la-Loire

HCL - Hopital Lyon Sud /ID# 200097, Pierre Benite CEDEX, Rhone

Centre Henri Becquerel /ID# 223186, Rouen, Seine-Maritime

CH Henri Duffaut /ID# 234154, Avignon CEDEX 9, Vaucluse

Robert-Bosch-Krankenhaus /ID# 223947, Stuttgart, Baden-Wuerttemberg

Universitaetsklinikum Tuebingen /ID# 238646, Tubingen, Baden-Wuerttemberg

Universitaetsklinikum Wuerzburg /ID# 200055, Wuerzburg, Bayern

Klinikum Chemnitz gGmbH /ID# 233797, Chemnitz, Sachsen

Universitaetsklinikum Schleswig-Holstein Campus Kiel /ID# 201830, Kiel, Schleswig-Holstein

Universitaetsklinikum Jena /ID# 201254, Jena, Thueringen

Charite Universitaetsklinikum Berlin - Campus Benjamin Franklin /ID# 200051, Berlin, Not set

Universitaetsklinikum Hamburg-Eppendorf /ID# 215495, Hamburg, Not set

Asklepios Klinik Altona /ID# 222506, Hamburg, Not set

Alexandra General Hospital /ID# 202386, Athens, Attiki

University General Hospital of Heraklion PA.G.N.I /ID# 222879, Heraklion, Kriti

General Hospital of Athens Evaggelismos and Ophthalmiatrio of Athens Polyclinic /ID# 213982, Athens, Not set

University Gen Hosp of Patra /ID# 201691, Patras, Not set

Theageneio Anticancer Hospital /ID# 213983, Thessaloniki, Not set

General Hospital of Thessaloniki George Papanikolaou /ID# 201692, Thessaloniki, Not set

Rambam Health Care Campus /ID# 169678, Haifa, H_efa

Bnai Zion Medical Center /ID# 169466, Haifa, H_efa

The Lady Davis Carmel Medical Center /ID# 222969, Haifa, H_efa

Duplicate_Assuta Ashdod Medical Center /ID# 222968, Ashdod, HaDarom

Soroka University Medical Center /ID# 218768, Be'er Sheva, HaDarom

The Chaim Sheba Medical Center /ID# 169778, Ramat Gan, Tel-Aviv

Tel Aviv Sourasky Medical Center /ID# 169437, Tel Aviv, Tel-Aviv

Hadassah /ID# 169474, Jerusalem, Yerushalayim

Rabin Medical Center /ID# 244611, Petah Tikva, Not set

Duplicate_IRCCS AOU di Bologna - Policlinico Sant'Orsola-Malpighi /ID# 170952, Bologna, Emilia-Romagna

A.O.U. CITTA' DELLA SALUTE E DELLA SCIENZA DI TORINO - Ospedale Molinette /ID# 170962, Torino, Piemonte

Irccs-Crob /Id# 170955, Rionero In Vulture, Potenza

Azienda Ospedaliero Universitaria delle Marche /ID# 170950, Ancona, Not set

Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico /ID# 212498, Milano, Not set

Azienda Ospedaliera Ospedali Riuniti Villa Sofia Cervello /ID# 222988, Palermo, Not set

Azienda Ospedaliera Santa Maria Terni /ID# 170948, Terni, Not set

Nagoya City University Hospital /ID# 170880, Nagoya shi, Aichi

The Jikei University Kashiwa Hospital /ID# 223031, Kashiwa-shi, Chiba

Kyushu University Hospital /ID# 171117, Fukuoka-shi, Fukuoka

Ogaki Municipal Hospital /ID# 171043, Ogaki-shi, Gifu

Gunma University Hospital /ID# 170966, Maebashi-shi, Gunma

Hiroshima Red Cross Hospital & Atomic-bomb Survivors Hospital /ID# 171255, Hiroshima-shi, Hiroshima

Kobe City Medical Center General Hospital /ID# 170992, Kobe-shi, Hyogo

Duplicate_National Hospital Organization Mito Medical Center /ID# 171187, Higashi Ibaraki-gun, Ibaraki

Hitachi General Hospital /ID# 200843, Hitachi-shi, Ibaraki

Iwate Medical University Hospital /ID# 222849, Shiwa-gun, Iwate

Tohoku University Hospital /ID# 201935, Sendai-shi, Miyagi

Okayama Medical Center /ID# 200119, Okayama-shi, Okayama

Japanese Red Cross Osaka Hospital /ID# 171493, Osaka-shi, Osaka

The University of Osaka Hospital /ID# 201966, Suita-shi, Osaka

Tokushima University Hospital /ID# 202571, Tokushima-shi, Tokushima

The Jikei University Hospital /ID# 239014, Minato-ku, Tokyo

Japanese Red Cross Medical Center /ID# 171256, Shibuya-ku, Tokyo

Yamagata University Hospital /ID# 238329, Yamagata-shi, Yamagata

Duplicate_Gachon University Gil Medical Center /ID# 202827, Incheon, Gyeonggido

Seoul National University Hospital /ID# 202711, Seoul, Seoul Teugbyeolsi

Samsung Medical Center /ID# 202710, Seoul, Seoul Teugbyeolsi

The Catholic University of Korea, Seoul St. Marys Hospital /ID# 234045, Seoul, Seoul Teugbyeolsi

Ulsan University Hospital /ID# 222716, Ulsan, Ulsan Gwang Yeogsi

Yonsei University Health System Severance Hospital /ID# 202709, Seoul, Not set

Moscow State budget healthcare /ID# 169685, Moscow, Moskva

Research Institute of Fundamental and Clinical Immunology /ID# 223594, Novosibirsk, Novosibirskaya Oblast

LLC Novaya Klinika /ID# 169689, Pyatigorsk, Stavropol Skiy Kray

City Clinical Hospital #52 /ID# 206289, Moscow, Not set

Leningrad Regional Clinical Hospital /ID# 202776, Saint Petersburg, Not set

Almazov National Medical Research Centre /ID# 169681, Sankt-Peterburg, Not set

Tula Regional Clinical Hospital /ID# 223226, Tula, Not set

National University Hospital /ID# 203988, Singapore, Not set

Singapore General Hospital /ID# 202131, Singapore, Not set

Tan Tock Seng Hospital /ID# 204374, Singapore, Not set

Hospital Universitari Son Espases /ID# 222889, Palma de Mallorca, Illes Balears

Hospital Costa del Sol /ID# 234083, Marbella, Malaga

Complejo Hospitalario Universitario Ourense /ID# 222876, Orense, Ourense

Hospital Universitario Canarias /ID# 238452, San Cristóbal de La Laguna, Santa Cruz De Tenerife

Hospital Universitario Vall d'Hebron /ID# 218106, Barcelona, Not set

Instituto Catalan de Oncologia (ICO) Girona /ID# 171311, Girona, Not set

Hospital de Leon /ID# 233878, Leon, Not set

Hospital Universitario Fundacion Jimenez Diaz /ID# 171304, Madrid, Not set

Hospital Universitario 12 de Octubre /ID# 171288, Madrid, Not set

Hospital Universitario La Paz /ID# 218107, Madrid, Not set

Hospital Universitario de Salamanca /ID# 171294, Salamanca, Not set

Hospital Universitario Virgen del Rocio /ID# 171286, Sevilla, Not set

Hospital General Universitario de Toledo /ID# 222887, Toledo, Not set

Hospital Universitario y Politecnico La Fe /ID# 234019, Valencia, Not set

Sunderby sjukhus /ID# 201314, Lulea, Norrbottens Lan

Sodra Alvsborgs sjukhus /ID# 213061, Boras, Vastra Gotalands Lan

Duplicate_Universitetssjukhuset Linköping /ID# 200789, Linkoping, Vastra Gotalands Lan

Uddevalla sjukhus /ID# 201315, Uddevalla, Vastra Gotalands Lan

Cukurova Universitesi Tip Fakultesi /ID# 201955, Saricam Adana, Adana

Izmir Ekonomi Universitesi Ozel Medicalpoint Hastanesi /ID# 201954, Karsiyaka, Izmir

Dr. Abdurrahman Yurtaslan Ankara Onkoloji Egitim ve Arastirma Hastanesi /ID# 201956, Ankara, Not set

Gazi University Medical Faculty /ID# 222698, Ankara, Not set

Ankara Univ Medical Faculty /ID# 201881, Ankara, Not set

Istanbul University Istanbul Medical Faculty /ID# 201953, Istanbul, Not set

Bagcilar Medipol Mega Universite Hastanesi /ID# 222914, Istanbul, Not set

Marmara Universitesi Pendik Egitim ve Arastirma Hastanesi /ID# 201952, Istanbul, Not set

Ege University Medical Faculty /ID# 222697, Izmir, Not set

Communal Nonprofit Enterprise Cherkasy Regional Oncology Dispensary /ID# 223943, Cherkasy, Cherkaska Oblast

Communal non-profit enterprise Regional Center of Oncology /ID# 223945, Kharkiv, Kharkivska Oblast

MNI Khmelnytskyi Regional Hospital of Khmelnytskyi Regional Council /ID# 223942, Khmelnytskyi, Not set

National Cancer Institute /ID# 223944, Kyiv, Not set

SI Institute of Blood Pathology and Transfusion Medicine of NAMS of Ukraine /ID# 223941, Lviv, Not set

Addenbrooke's Hospital /ID# 223097, Cambridge, Cambridgeshire

Hammersmith Hospital /ID# 171446, London, England

University College London Hospital /ID# 171428, London, Greater London

Norfolk and Norwich University Hospitals NHS Foundation Trust /ID# 218213, Norwich, Norfolk

Duplicate_Nottingham University Hospitals NHS Trust /ID# 223292, Nottingham, Nottinghamshire

Duplicate_NHS Greater Glasgow and Clyde /ID# 202199, Glasgow, Scotland

Duplicate_University Hospitals North Midlands - Royal Stoke University Hospital /ID# 218355, Stoke-on-Trent, Staffordshire

Duplicate_Duplicate_Lewisham and Greenwich NHS Trust /ID# 171445, London, Not set

Manchester University NHS Foundation Trust /ID# 171440, Manchester, Not set

Portsmouth Hospitals University NHS Trust /ID# 171444, Portsmouth, Not set

Royal Berkshire NHS Foundation Trust /ID# 217835, Reading, Not set

Duplicate_Sheffield Teaching Hospitals NHS Foundation Trust - Royal Hallamshire /ID# 171447, Sheffield, Not set

Conditions: Multiple Myeloma

Learn More ›

MagnetisMM-4: Umbrella Study of Elranatamab (PF-06863135) in Combination With Anti-Cancer Treatments in Multiple Myeloma

NCT05090566

Recruiting

The purpose of this study is to determine the Recommended Phase 2 Dose and clinical benefit of elranatamab in combination with other anti-cancer therapies in participants with multiple myeloma.

Gender:

ALL

Ages:

18 years and above

Trial Updated:

06/05/2025

Locations: Banner Gateway Medical Center, Gilbert, Arizona +28 locations

Banner Gateway Medical Center, Gilbert, Arizona

Banner Gateway Medical Pavilion, Gilbert, Arizona

Banner MD Anderson Cancer Center, Gilbert, Arizona

University of Arkansas for Medical Sciences - Winthrop P. Rockefeller Cancer Institute, Little Rock, Arkansas

Beverly Hills Cancer Center, Beverly Hills, California

Clinical Research Advisors, Encino, California

Clinical Research Advisors, Los Angeles, California

Cedars Sinai Medical Center Oncology IDS Pharmacy Attn:Suwicha Limvorasak ,PharmaD, Los Angeles, California

Cedars Sinai Medical Center, Los Angeles, California

Cedars-Sinai Medical Center, Samuel Oschin Comprehensive Cancer Institute (SOCCI), Los Angeles, California

Clinical Research Advisors, Los Angeles, California

Sylvester Comprehensive Cancer Center - The Lennar Foundation Medical Center, Coral Gables, Florida

Sylvester Comprehensive Cancer Center- Deerfield Beach, Deerfield Beach, Florida

Sylvester Comprehensive Cancer Center, Miami, Florida

UHealth Tower, Miami, Florida

UChicago Medicine - River East, Chicago, Illinois

University of Chicago Medical Center, Chicago, Illinois

UChicago Medicine at Ingalls - Flossmoor, Flossmoor, Illinois

UChicago Medicine Ingalls Memorial, Harvey, Illinois

University of Chicago Comprehensive Cancer Center at Silver Cross Hospital, New Lenox, Illinois

The University of Chicago Medicine Center for Advanced Care Orland Park, Orland Park, Illinois

UChicago Medicine at Ingalls - Tinley Park, Tinley Park, Illinois

OIDS, The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, Maryland

The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins (Also Imaging Facility), Baltimore, Maryland

Massachusetts General Hospital, Boston, Massachusetts

Beth Israel Deaconess Medical Center, Boston, Massachusetts

Arthur J.E. Child Comprehensive Cancer Centre, Calgary, Alberta

The Ottawa Hospital - General Campus, Ottawa, Ontario

Princess Margaret Cancer Centre, Toronto, Ontario

Conditions: Multiple Myeloma

Learn More ›

A Study to Evaluate Mezigdomide, Bortezomib and Dexamethasone (MEZIVd) Versus Pomalidomide, Bortezomib and Dexamethasone (PVd) in Participants With Relapsed or Refractory Multiple Myeloma (RRMM)

NCT05519085

Recruiting

The purpose of this study is to compare the efficacy and safety of mezigdomide (CC-92480), bortezomib and dexamethasone (MeziVd) versus pomalidomide, bortezomib and dexamethasone (PVd) in participants with relapsed or refractory multiple myeloma (RRMM) who received between 1 to 3 prior lines of therapy and who have had prior lenalidomide exposure.

Gender:

ALL

Ages:

18 years and above

Trial Updated:

06/05/2025

Locations: Cancer and Blood Specialty Clinic, Los Alamitos, California +263 locations

Cancer and Blood Specialty Clinic, Los Alamitos, California

Sharp Memorial Hospital, San Diego, California

Private Practice - Dr. James R. Berenson, West Hollywood, California

Local Institution - 0381, Aurora, Colorado

UConn Health, Farmington, Connecticut

Local Institution - 0208, New Haven, Connecticut

Advanced Research, Coral Springs, Florida

Florida Cancer Specialists - South, Fort Myers, Florida

Florida Cancer Specialists - North, Saint Petersburg, Florida

Florida Cancer Specialists - East, West Palm Beach, Florida

University Cancer Blood Ctr, Athens, Georgia

Local Institution - 0048, Marietta, Georgia

Local Institution - 0330, Garden City, Kansas

University of Kansas Medical Center, Westwood, Kansas

Our Lady of the Lake RMC, Baton Rouge, Louisiana

Tulane Cancer Center, New Orleans, Louisiana

Local Institution - 0385, Shreveport, Louisiana

Sinai Hospital Of Baltimore, Baltimore, Maryland

Dana-Farber Cancer Institute, Boston, Massachusetts

University of Michigan, Ann Arbor, Michigan

Henry Ford Hospital, Detroit, Michigan

Minnesota Oncology Hematology, P.A., Minneapolis, Minnesota

Hattiesburg Clinic Hematology/Oncology, Hattiesburg, Mississippi

Local Institution - 0242, Jackson, Mississippi

Astera Cancer Care, East Brunswick, New Jersey

Local Institution - 0363, Ridgewood, New Jersey

University of New Mexico Comprehensive Cancer Center, Albuquerque, New Mexico

New York Cancer and Blood Specialists, Bronx, New York

Local Institution - 0245, Buffalo, New York

Northwell Health/ RJ Zuckerberg Cancer Center, Lake Success, New York

New York Cancer and Blood Specialists, New Hyde Park, New York

New York Cancer and Blood Specialists, New York, New York

Rochester General Hospital, Rochester, New York

New York Cancer and Blood Specialists, Shirley, New York

Local Institution - 0274, Williamsville, New York

Duke Cancer Institute, Durham, North Carolina

Oncology Hematology Care, Cincinnati, Ohio

Fairview Hospital, Cleveland, Ohio

Cleveland Clinic, Cleveland, Ohio

Cleveland Clinic - Hillcrest Hospital, Mayfield Heights, Ohio

Lehigh Valley Health Network, Allentown, Pennsylvania

Local Institution - 0264, York, Pennsylvania

The West Clinic, PLLC dba West Cancer Center, Germantown, Tennessee

Texas Oncology - West Texas, Abilene, Texas

University of Texas MD Anderson Cancer Center, Houston, Texas

Mays Cancer Center, San Antonio, Texas

Texas Oncology - San Antonio, San Antonio, Texas

Utah Cancer Specialists, Salt Lake City, Utah

Hematology Oncology Associates of Fredericksburg, Fredericksburg, Virginia

Virginia Oncology Associates, Norfolk, Virginia

Blue Ridge Cancer Care, Roanoke, Virginia

VA Puget Sound Health Care System, Seattle, Washington

Local Institution - 0293, Seattle, Washington

Local Institution - 0097, Spokane, Washington

Northwest Cancer Specialists, P.C., Vancouver, Washington

Local Institution - 0220, Madison, Wisconsin

Sanatorio Chivilcoy, Chivilcoy, Buenos Aires

Hospital Privado Universitario de Córdoba, Cordoba, Córdoba

Clinica Viedma S. A, Viedma, R

Hospital Privado de Rosario, Rosario, Santa FE

Centro Mdico "Barrio Parque", Buenos Aires, Not set

Hospital Británico de Buenos Aires, Buenos Aires, Not set

Clínica de Nefrología, Urología y Enfermedades Cardiovasculares, Santa Fe, Not set

Liverpool Hospital, Liverpool, New South Wales

Calvary Mater Newcastle, Waratah, New South Wales

Wollongong Hospital-Illawarra Cancer Care Centre, Wollongong, New South Wales

Sunshine Coast University Hospital, Birtinya, Queensland

Box Hill Hospital, Box Hill, Victoria

The Alfred Hospital, Melbourne, Victoria

St Vincent's Hospital, Melbourne, Victoria

Sir Charles Gairdner Hospital, Nedlands, Western Australia

Klinik Ottakring, Vienna, Wien

Universitätsklinikum Krems, Krems an der Donau, Not set

LKH Hochsteiermark - Standort Leoben, Leoben, Not set

Universitätsklinikum St. Pölten, St. Pölten, Not set

Hanusch-Krankenhaus, Wien, Not set

Ziekenhuis Oost-Limburg, Campus St.-Jan, Genk, Limburg

UZ Gent, Gent, Oost-Vlaanderen

AZ Nikolaas, Sint-Niklaas, Oost-Vlaanderen

ZNA Cadix, Antwerpen, Not set

Instituto D'Or de Pesquisa e Ensino (IDOR) - Filial Salvador, Salvador, Bahia

Centro Gaucho Integrado De Oncologia, Hematologia, Ensino E Pesquisa, Porto Alegre, Rio Grande Do Sul

Instituto Joinvilense de Hematologia e Oncologia, Joinville, Santa Catarina

Hospital Amaral Carvalho, Jau, São Paulo

Americas Centro de Oncologia Integrado, Rio de Janeiro, Not set

Clínica Médica São Germano S/S Ltda, Sao Paulo, Not set

Sociedade Beneficente Israelita Brasileira Hospital Albert Einstein, Sao Paulo, Not set

Centre Intégré de Santé et de Services Sociaux de la Montérégie-Centre, Greenfield Park, Quebec

Centre intégré universitaire de santé et de services sociaux du Nord-de-l'Île-de-Montréal (CIUSSS NÎM) - Hôpital du Sacré-Coeur, Montreal, Quebec

Centre intégré de cancérologie du CHU de Québec Université Laval, Hôpital de l'Enfant-Jésus, Quebec City, Quebec

Clínica Inmunocel, Santiago, Región Metropolitana De Santiago

Bradfordhill, Santiago, Región Metropolitana De Santiago

Centro de Investigaciones, Viña del Mar, Valparaíso

Beijing Chaoyang Hospital, Capital Medical University, Beijing City, Beijing

Local Institution - 0165, Beijing City, Beijing

Local Institution - 0141, Beijing, Beijing

The First Afffiliated Hospital of Chongqing Medical University, Chongqing, Chongqing

The First Affiliated hospital of Xiamen University, Xiamen, Fujian

Henan Cancer Hospital, Guangzhou, Guangdong

Sun Yat-sen University Cancer Center, Guangzhou, Guangdong

Local Institution - 0168, Guangzhou, Guangdong

Shenzhen Second People's Hospital, Shenzhen, Guangdong

Local Institution - 0412, Liuzhou, Guangxi

Guangxi Medical University No.1 Affiliated Hospital, Nanning, Guangxi

The First Hospital of Hebei Medical University, Shijiazhuang, Hebei

Local Institution - 0395, Luoyang, Henan

People's Hospital of Henan Province, Zhengzhou, Henan

Wuhan Union Hospital, Wuhan, Hubei

Xiangya Hospital Central South University, Changsha, Hunan

The Third Xiangya Hospital of Central South University, Changsha, Hunan

Nanjing Drum Tower Hospital The Affiliated Hospital of Nanjing University Medical School, Nanjing, Jiangsu

Wuxi People's Hospital, Wuxi, Jiangsu

Shengjing Hospital of China Medical University, Shenyang, Liaoning

The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'An, Shaanxi

Local Institution - 0110, Xi'an, Shaanxi

The Affiliated Hospital of Qingdao University, Qingdao, Shandong

Shanghai 6th people's hospital, Shanghai, Shanghai

Tongji University - Shanghai Fourth People's Hospital, Shanghai, Shanghai

First Affiliated Hospital of Shanxi Medical University, Taiyuan, Shanxi

Local Institution - 0356, Deyang, Sichuan

Tianjin Medical University Cancer Institute and Hospital, Tianjin, Tianjin

Local Institution - 0353, Urumqi, Xinjiang

First Affiliated Hospital of Kunming Medical University, Kunming, Yunnan

Local Institution - 0151, Hangzhou, Zhejiang

Taizhou Hospital of Zhejiang Province, Linhai, Zhejiang

Ningbo First Hospital, Ningbo, Zhejiang

The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang

Peking University First Hospital, Beijing, Not set

Shanxi Bethune Hospital, Taiyuan, Not set

Fakultní nemocnice Brno Bohunice, Brno, Brno-město

Fakultni nemocnice Kralovske Vinohrady, PRague, Praha 10

Vseobecna fakultni nemocnice v Praze, Praha, Not set

Kuopion Yliopistollinen Sairaala, Kuopio, Pohjois-Savo

Helsinki University Hospital - Comprehensive Cancer Center (HYKS - Syöpäkeskus), Helsinki, Not set

Institut de cancérologie Strasbourg Europe (ICANS), Strasbourg, Alsace

CHU Bordeaux Haut-Leveque, Pessac, Aquitaine

Hopital Claude Huriez - CHU de Lille, Lille, Nord

Centre Leon Berard, Lyon Cedex08, Rhône-Alpes

Centre Hospitalier Universitaire Estaing, Clermont-Ferrand, Not set

Centre Hospitalier Universitaire de Limoges - Hôpital Dupuytren, Limoges, Not set

Centre Hospitalier Universitaire de Nantes - L' Hopital l'hôtel-Dieu, Nantes, Not set

Centre Hospitalier Universitaire de Nîmes - Institut de Cancérologie du Gard - Hôpital Universitaire Carémeau, Nîmes, Not set

Centre Hospitalier Régional Universitaire de Tours - Hôpital Bretonneau, Tours, Not set

Hôpital Saint Antoine, Paris, Île-de-France

TUM Universitätsklinikum, Technische Universität München, München, Bayern

Klinikum Traunstein, Traunstein, Bayern

Medizinisches Versorgungszentrum, Weiden, Bayern

Universitätsklinikum Marburg, Marburg, Hessen

Local Institution - 0414, Hannover, Niedersachsen

Universitätsklinikum Bonn, Bonn, Nordrhein-Westfalen

Local Institution - 0415, Düsseldorf, Nordrhein-Westfalen

Universitaetsklinikum Schleswig-Holstein Campus Kiel, Kiel, Schleswig-Holstein

Local Institution - 0396, Erfurt, Thüringen

Universitätsklinikum Aachen, Aachen, Not set

Sozialstiftung Bamberg, Bamberg, Not set

Local Institution - 0413, Dresden, Not set

Universitaetsklinikum Hamburg-Eppendorf, Hamburg, Not set

Asklepios Altona, Hamburg, Not set

Universitaetsklinikum Tuebingen, Tuebingen, Not set

Gemeinschaftspraxis Dres. med. Björn Schöttker & Dominik Pretscher, Würzburg, Not set

Evangelismos General Hospital of Athens, Athens, Attikí

Alexandra General Hospital of Athens, Athens, Attikí

G. Papanikolaou General Hospital, Thessaloniki, Thessaloníki

HCG Aastha Cancer Centre, Ahmedabad, Gujarat

Marengo Asia Hospitals Gurugram, Gurugram, Haryana

KLES Dr. Prabhakar Kore Hospital & M.R.C, Belagavi, Karnataka

Meenakshi Mission Hospital and Research Centre, Madurai, Tamil Nadu

Local Institution - 0341, Varanasi, Uttar Pradesh

Christian Medical College & Hospital, Ludhiana, Not set

Jawaharlal Institute Of Postgraduate Medical Education And Research, Puducherry, Not set

University College Hospital - Galway, Galway, Connaught

Cork University Hospital, Cork, Not set

St. James's Hospital, Dublin, Not set

Local Institution - 0251, Limerick, Not set

Meir Medical Center, Kfar Saba, HaMerkaz

Sheba Medical Center, Ramat Gan, HaMerkaz

Rambam Health Care Campus, Haifa, HaTsafon

Sourasky Medical Center, Tel Aviv, Tall Abīb

Hadassah Medical Center - Do Not Use - Duplicate Facility, Jerusalem, Yerushalayim

Rabin Medical Center, Peatch Tikva, Not set

IRCCS - Istituto Romagnolo per lo Studio dei Tumori (IRST) "Dino Amadori", Meldola, Emilia-Romagna

Policlinico "G. Rodolico", Catania, Sicilia

IRCCS Azienda Ospedaliero-Universitaria di Bologna, Policlinico di Sant'Orsola, Bologna, Not set

Fondazione IRCCS Policlinico San Matteo, Pavia, Not set

Azienda Ospedaliera Sant'Andrea, Roma, Not set

National Cancer Center Hospital East, Kashiwa, Chiba

Japan Community Healthcare Organization Kyushu Hospital, Kitakyushu-shi, Fukuoka

National Hospital Organization Hokkaido Cancer Center, Sapporo, Hokkaido

Iwate Medical University Hospital, Shiwa-gun Yahaba-cho, Iwate

Shonan Kamakura General Hospital, Kamakura, Kanagawa

Saitama Medical University Hospital, Iruma, Saitama

Dokkyo Medical University Saitama Medical Center, Koshigaya, Saitama

Shizuoka Cancer Center, Nagaizumi-cho,Sunto-gun, Shizuoka

Nihon University Itabashi Hospital, Itabashiku, Tokyo

Chiba University Hospital, Chiba, Not set

National Hospital Organization Kyushu Medical Center, Fukuoka, Not set

Japanese Red Cross Fukuoka Hospital, Fukuoka, Not set

Hiroshima Red Cross Hospital & Atomic-bomb Survivors Hospital, Hiroshima, Not set

Kumamoto University, Kumamoto, Not set

The Japanese Red Cross Nagasaki Genbaku Hospital, Nagasaki, Not set

The Jikei University Hospital, Tokyo, Not set

Japanese Red Cross Medical Center, Tokyo, Not set

Local Institution - 0106, Busan, Busan-gwangyeoksi

Pusan National University Hospital, Busan, Busan-gwangyeoksi

Local Institution - 0102, Seongnam, Gyeonggido

Seoul National University Bundang Hospital, Seongnam, Gyeonggido

Chonnam National University Hwasun Hospital, Hwasun, Jeonranamdo

Local Institution - 0103, Hwasun, Jeonranamdo

Local Institution - 0101, Seoul, Seoul Teugbyeolsi

Seoul National University Hospital, Seoul, Seoul Teugbyeolsi

Samsung Medical Center, Seoul, Seoul Teugbyeolsi

Local Institution - 0104, Seoul, Seoul Teugbyeolsi

The Catholic Univ. of Korea Seoul St. Mary's Hospital, Seoul, Seoul Teugbyeolsi

Asan Medical Center, Seoul, Seoul-teukbyeolsi [Seoul]

Local Institution - 0105, Seoul, Seoul-teukbyeolsi

Local Institution - 0100, Seoul, Not set

Severance Hospital, Yonsei University Health System, Seoul, Not set

Local Institution, Seoul, Not set

Tauranga Hospital, Tauranga, Bay Of Plenty

Dunedin Hospital, Dunedin, Otago

Auckland City Hospital, Auckland, Not set

Local Institution - 0334, Auckland, Not set

MICS Centrum Medyczne Torun, Torun, Kujawsko-pomorskie

Instytut Hematologii i Transfuzjologii, Warsaw, Mazowieckie

Local Institution - 0325, Kraków, Małopolskie

Local Institution - 0292, Słupsk, Pomorskie

Local Institution - 0346, Skórzewo, Wielkopolskie

Pratia Onkologia Katowice, Katowice, Not set

Hospital de Braga, Braga, Not set

Champalimaud Foundation, Lisbon, Not set

Instituto Português de Oncologia do Porto Francisco Gentil, EPE, Porto, Not set

Local Institution - 0355, San Juan, Not set

Fundeni Clinical Institute, Bucharest, Not set

Institutul Oncologic Cluj, Cluj Napoca, Not set

Institutul Regional de Oncologie Iasi, Iasi, Not set

Local Institution - 0405, Centurion, GP

Local Institution - 0404, Cape Town, Western Cape

Local Institution - 0407, Kuilsriver, Western Cape

Local Institution - 0406, Plumstead, Western Cape

Hospital Universitari Son Espases, Palma, Balears [Baleares]

Hospital Clínic de Barcelona, Barcelona, Catalunya [Cataluña]

Local Institution - 0073, Barcelona, Catalunya [Cataluña]

Local Institution - 0183, Palma, Illes Balears

Hospital General Universitario Morales Meseguer, Murcia, Murcia, Región De

Hospital Costa del Sol, Marbella, Málaga

Local Institution - 0182, Marbella, Málaga

Hospital San Pedro de Alcantara, Cáceres, Not set

Complejo Asistencial Universitario de León - Hospital de León, León, Not set

Hospital Universitario 12 de Octubre, Madrid, Not set

Ankara University Health Practice and Research Hospitals, Ankara, Not set

Liv Hospital Ankara, Ankara, Not set

Istanbul University, Istanbul Faculty of Medicine, Istanbul, Not set

Ege Universitesi Hastanesi, İzmir, Not set

Erciyes Universitesi Tıp Fakultesi Hastaneleri, Kayseri, Not set

Ondokuz Mayıs Universitesi, Samsun, Not set

Addenbrooke's Hospital, Cambridge, Cambridgeshire

The Royal Cornwall Hospital, Truro, England

Lanarkshire NHS Trust - Monklands Hospital, Airdrie, Great Britain

King's College Hospital, London, Greater London

Leicester Royal Infirmary, Leicester, Leicestershire

Hammersmith Hospital, London, London, City Of

Barnet Hospital, Barnet, Not set

Freeman Hospital, Newcastle upon Tyne, Not set

Royal Stoke University Hospital, Stoke-on-Trent, Not set

Conditions: Relapsed or Refractory Multiple Myeloma

Learn More ›

Improving White Blood Cell Collection From Healthy Donors

NCT01553214

Recruiting

Background: - White blood cells called granulocytes help the body fight infection. People who have had chemotherapy or bone marrow transplants may have very low numbers of these cells. Transfusions of these cells can help improve the body's ability to fight infection. However, most of the cells are located in the bone marrow or spleen, and are hard to collect from healthy donors. Two drugs, filgrastim and dexamethasone, can help move the cells to the bloodstream to be collected by apheresis. Re... Read More

Gender:

ALL

Ages:

Between 18 years and 75 years

Trial Updated:

06/05/2025

Locations: National Institutes of Health Clinical Center, Bethesda, Maryland

Conditions: Allogeneic Granulocyte Donation

Learn More ›

A Pivotal Safety and Efficacy Study of OCS-01 Eye Drops in Participants With Diabetic Macular Edema (DIAMOND 1)

NCT05066997

Active Not Recruiting

The primary objective of this study is to evaluate the efficacy and safety of the topical ophthalmic administration of OCS- 01 as compared to Vehicle in participants with Diabetic Macular Edema (DME).

Gender:

ALL

Ages:

Between 18 years and 85 years

Trial Updated:

06/04/2025

Locations: Arizona Retina and Vitreous Consultants, Phoenix, Arizona +55 locations

Arizona Retina and Vitreous Consultants, Phoenix, Arizona

Phoenix Retina Associates, Phoenix, Arizona

Retina Partners of Northwest Arkansas, Springdale, Arkansas

Retina-Vitreous Associates Medical Group, Beverly Hills, California

The Retina Partners, Encino, California

Retinal Consultants Medical Group, Modesto, California

California Eye Specialists Medical Group, Pasadena, California

California Eye Specialists Medical Group, Redlands, California

Retina Consultants of Southern California, Redlands, California

California Retina Consultants, Santa Maria, California

Beverly Hills Institute of Ophthalmology, Torrance, California

Retina Group Of New England, Waterford, Connecticut

Rand Eye Institute, Deerfield Beach, Florida

Florida Retina Institute, Jacksonville, Florida

MedEye Associates, Miami, Florida

Florida Retina Institute, Orlando, Florida

Retina Care Specialists, Palm Beach Gardens, Florida

East Florida Eye Institute, Stuart, Florida

Southeast Retina Center, Augusta, Georgia

Retina Associates, Elmhurst, Illinois

University Retina, Lemont, Illinois

Midwest Eye Institute, Carmel, Indiana

Cumberland Valley Retina Consultants, Hagerstown, Maryland

Retina Consultants of Minnesota, St. Louis Park, Minnesota

The Retina Institute, Saint Louis, Missouri

Retina-Vitreous Surgeons of Central New York, Liverpool, New York

North Carolina Retina Associates, Wake Forest, North Carolina

Velocity (Meridian) Clinical Research, Cincinnati, Ohio

Verum Research LLC, Eugene, Oregon

Vision Research Solutions in Philadelphia, Philadelphia, Pennsylvania

Retina Consultants of Charleston, Beaufort, South Carolina

Charleston Neuroscience Institute, Ladson, South Carolina

Black Hills Regional Eye Institute, Rapid City, South Dakota

Retina Research Institute of Texas, Abilene, Texas

Retina Consultants of Austin/Austin Research Center for Retina, Austin, Texas

Retina Consultants of Texas, Beaumont, Texas

Texas Retina Associates, Dallas, Texas

Retina Center of Texas, Grapevine, Texas

Valley Retina Institute PA d.b.a. Gulf Coast Eye Institute, McAllen, Texas

Retina Consultants of Texas, The Woodlands, Texas

Tyler Retina Consultants, Tyler, Texas

Strategic Clinical Research Group, Willow Park, Texas

Piedmont Eye Center, Lynchburg, Virginia

HKU Eye Centre, Hong Kong, Not set

Chinese University of Hong Kong Eye Centre, Kowloon, Not set

Shivam Retina Clinic and Eye Hospital, Surat, Gujarat

Nethra Eye Hospital, Bengaluru, Karnataka

Amrita Institute of Medical Sciences & Research Centre, Kochi, Kerala

Sarakshi Netralaya, Nagpur, Maharashtra

L V Prasad Eye Institute, Bhubaneswar, Orissa

ICARE Eye Hospital & Post Graduate Institute, Noida, Uttar Pradesh

Changhua Christian Hospital, Changhua City, Changhua

China Medical University Hospital, Taichung City, Taichung

Taipei Veterans General Hospital, Taipei, Not set

Tri-Service General Hospital, Taipei, Not set

Chang Gung Memorial Hospital, Taoyuan, Not set

Conditions: Diabetic Macular Edema

Learn More ›

Ibrutinib, Rituximab, and Consolidation Chemotherapy in Treating Young Patients With Newly Diagnosed Mantle Cell Lymphoma

NCT02427620

Active Not Recruiting

This phase II trial studies how well ibrutinib, rituximab, and consolidation chemotherapy consisting of cyclophosphamide, vincristine sulfate, doxorubicin hydrochloride, dexamethasone, methotrexate, and cytarabine work in treating young patients with newly diagnosed mantle cell lymphoma. Ibrutinib may stop the growth of cancer cells by blocking some of the enzymes needed for cell growth. Immunotherapy with monoclonal antibodies, such as rituximab, may help the body's immune system attack the can... Read More

Gender:

ALL

Ages:

Between 18 years and 65 years

Trial Updated:

06/04/2025

Locations: M D Anderson Cancer Center, Houston, Texas

Conditions: Blastoid Variant Mantle Cell Lymphoma, Mantle Cell Lymphoma, Pleomorphic Variant Mantle Cell Lymphoma

Learn More ›

A Pivotal Safety and Efficacy Study of OCS-01 Eye Drops in Participants With Diabetic Macular Edema (DIAMOND 2)

NCT06172257

Active Not Recruiting

The primary objective of this study is to evaluate the efficacy and safety of the topical ophthalmic administration of OCS 01 as compared to Vehicle in participants with Diabetic Macular Edema (DME).

Gender:

ALL

Ages:

Between 18 years and 85 years

Trial Updated:

06/04/2025

Locations: Associated Retina Consultants, Gilbert, Arizona +62 locations

Associated Retina Consultants, Gilbert, Arizona

Associated Retina Consultants, Phoenix, Arizona

Retinal Consultants of Arizona - Phoenix North, Phoenix, Arizona

California Retina Consultants, Bakersfield, California

Retina Associates of Southern California, Huntington Beach, California

Stanford Byers Eye Institute, Palo Alto, California

Retinal Consultants Medical Group, Inc, Sacramento, California

Retinal Consultants Medical Group, Sacramento, California

California Retina Consultants, Santa Barbara, California

Macula Retina Vitreous Center, Torrance, California

Retina Specialists of Colorado, Denver, Colorado

Eye Care Center of Northern Colorado, Longmont, Colorado

Sibia Eye Institute, Boynton Beach, Florida

Blue Ocean Clinical Research, Clearwater, Florida

Advanced Research, Coral Springs, Florida

Retina Group of Florida, Fort Lauderdale, Florida

East Coast Institute for Research, Jacksonville, Florida

Retina Consultants of Southwest Florida, Naples, Florida

Marietta Eye Clinic, Marietta, Georgia

Georgia Retina, Peachtree City, Georgia

Illinois Retina Associates, Oak Park, Illinois

Cumberland Valley Retina Consultants, Hagerstown, Maryland

Mid Atlantic Retina Specialists, Hagerstown, Maryland

Ophthalmic Consultants of Boston, Boston, Massachusetts

Mississippi Retina Associates, Jackson, Mississippi

Sierra Eye Associates, Reno, Nevada

VitreoRetinal Consultants of NY, Hauppauge, New York

Island Retina, Shirley, New York

Vitreoretinal Consultants of NY, Westbury, New York

Erie Retina Research, Erie, Pennsylvania

Vision Research Solutions in Philadelphia, Philadelphia, Pennsylvania

Palmetto Retina Center, West Columbia, South Carolina

Charles Retina Institute, Germantown, Tennessee

Tennessee Retina, Nashville, Tennessee

Retina Consultants of Texas, Bellaire, Texas

Star Retina, Burleson, Texas

Houston Eye Associates, North Loop, Houston, Texas

Austin Retina Associates, Round Rock, Texas

San Antonio Eye Center - Downtown Clinic, San Antonio, Texas

Retina Consultants of Texas, San Antonio, Texas

Medical Center Ophthalmology Associates, San Antonio, Texas

Tyler Retina Consultants, Tyler, Texas

Piedmont Eye Center, Lynchburg, Virginia

Centro De Ojos Loria Srl, Caba, Buenos Aires

Centro Privado de Ojos, Caba, Buenos Aires

Organizacion Medica De Investigacion, Caba, Buenos Aires

Buenos Aires Macula (BAM) Clinical Research, Caba, Buenos Aires

Charles Centro Oftalmológico, Ciudad Autónoma de Buenos Aires, Buenos Aires

Centro Privado de Ojos Romagosa, Cordoba, Córdoba

Grupo Laser Vision, Rosario, Santa Fe

Oftalmologìa Global, Rosario, Santa Fe

Fundacion Zambrano, Buenos Aires, Not set

Oftalmos - Instituto Oftalmológico de Alta Complejidad, Buenos Aires, Not set

Instituto de Microcirugía Ocular Córdoba (IMOC), Córdoba, Not set

Oftar Mendoza - Centro Privado de Oftalmología en Mendoza Capital, Mendoza, Not set

Centro de la Vision Dr. Kolton, Salta, Not set

Rising Retina Clinic, Ahmedabad, Gujarat

Narayana Nethralaya, Bangalore, Karnataka

Agrawal Hospital, Jaipur, Rajasthan

Lotus Eye Hospital and Institute, Coimbatore, Tamil Nadu

St. Theresa's Hospital, Hyderabad, Telangana

GSVM Medical College, Kanpur, Uttar Pradesh

Emanuelli Research & Development Center, Arecibo, Not set

Conditions: Diabetic Macular Edema

Learn More ›

Pomalidomide in Combination With Low-dose Dexamethasone or Pomalidomide in Combination With Low-dose Dexamethasone and Daratumumab in Subjects With Relapsed or Refractory Multiple Myeloma Following Lenalidomide-based Therapy in the First or Second Line Setting

NCT01946477

Completed

This trial will evaluate the efficacy and safety of combination of pomalidomide (POM) and low-dose dexamethasone (LD-Dex) (Cohort A) or the combination of pomalidomide (POM) , daratumumab (DARA) and low-dose dexamethasone (LD-Dex) (Cohort B) in subjects with relapsed or refractory multiple myeloma who have received a first or second line treatment of lenalidomide-based therapy. This trial will test the hypothesis for Cohort A that the proportion of patients will have an Overall Response Rate (O... Read More

Gender:

ALL

Ages:

18 years and above

Trial Updated:

06/04/2025

Locations: Local Institution - 126, Tucson, Arizona +48 locations

Local Institution - 126, Tucson, Arizona

Local Institution - 137, Greenbrae, California

Local Institution - 109, Los Angeles, California

Local Institution - 104, Pleasant Hill, California

Local Institution - 108, Whittier, California

Local Institution - 138, Denver, Colorado

Local Institution - 120, Stamford, Connecticut

Local Institution - 145, Jacksonville, Florida

Local Institution - 127, Orlando, Florida

Local Institution - 133, Pembroke Pines, Florida

Local Institution - 136, Saint Petersburg, Florida

Local Institution - 134, Fairway, Kansas

Local Institution - 142, Topeka, Kansas

Local Institution - 124, Louisville, Kentucky

Local Institution - 103, Westminster, Maryland

Local Institution - 146, Gross Pointe, Michigan

Local Institution - 102, Kansas City, Missouri

Local Institution - 110, Saint Louis, Missouri

Local Institution - 118, East Orange, New Jersey

Local Institution - 101, Hackensack, New Jersey

Local Institution - 149, Bronx, New York

Local Institution - 129, Glens Falls, New York

Local Institution - 130, Durham, North Carolina

Local Institution - 123, Cleveland, Ohio

Local Institution - 121, Cleveland, Ohio

Local Institution - 115, Cleveland, Ohio

Local Institution - 122, Mayfield Heights, Ohio

Local Institution - 107, Hershey, Pennsylvania

Local Institution - 135, Chattanooga, Tennessee

Local Institution - 131, Nashville, Tennessee

Local Institution - 128, Lubbock, Texas

Local Institution - 143, Plano, Texas

Local Institution - 106, Spokane, Washington

Local Institution - 113, Calgary, Alberta

Local Institution - 144, Surrey, British Columbia

Local Institution - 114, Vancouver, British Columbia

Local Institution - 139, Moncton, New Brunswick

Local Institution - 140, St John's, Newfoundland and Labrador

Local Institution - 112, Toronto, Ontario

Local Institution - 148, Toronto, Ontario

Local Institution - 117, Montreal, Quebec

Local Institution - 205, Fukuoka, Not set

Local Institution - 208, Kamogawa, Not set

Local Institution - 204, Kyoto-city, Not set

Local Institution - 202, Nagoya, Not set

Local Institution - 203, Okayama, Not set

Local Institution - 206, Shibukawa-shi, Gunma-ken, Not set

Local Institution - 207, Toyohashi, Not set

Local Institution - 119, San Juan, Not set

Conditions: Multiple Myeloma

Learn More ›

A Phase II Study of Perioperative Paclitaxel in Patients With Gastric Adenocarcinoma and Carcinomatosis or Positive Cytology

NCT05977998

Recruiting

To learn about the effects of paclitaxel and gastrectomy (surgery to remove all or part of the stomach) on improving outcomes in patients with gastric cancer.

Gender:

ALL

Ages:

18 years and above

Trial Updated:

06/03/2025

Locations: M D Anderson Cancer Center, Houston, Texas

Conditions: Gastric Adenocarcinoma, Carcinomatosis

Learn More ›

Continuing Treatment for Participants Who Have Participated in a Prior Protocol Investigating Elotuzumab

NCT02719613

Active Not Recruiting

The purpose of this study is to continue to provide elotuzumab and/or other study drugs to participants who have participated on a prior protocol investigating elotuzumab who are not able to receive commercial drug supply.

Gender:

ALL

Ages:

18 years and above

Trial Updated:

06/03/2025

Locations: Local Institution - 0020, Tucson, Arizona +40 locations

Local Institution - 0020, Tucson, Arizona

Local Institution - 0017, Bakersfield, California

Local Institution - 0022, Fountain Valley, California

Local Institution - 0016, West Hollywood, California

Local Institution - 0019, Denver, Colorado

Local Institution - 0021, Jacksonville, Florida

Local Institution - 0042, Saint Petersburg, Florida

Local Institution - 0009, Atlanta, Georgia

Local Institution - 0003, Indianapolis, Indiana

Local Institution - 0002, Boston, Massachusetts

Local Institution - 0008, Saint Louis, Missouri

Local Institution - 0004, New York, New York

Local Institution - 0001, Bethlehem, Pennsylvania

Local Institution - 0018, Dallas, Texas

Local Institution - 0034, Heidelberg, Victoria

Local Institution - 0023, Antwerpen, Not set

Local Institution - 0011, Toronto, Ontario

Local Institution - 0010, Halifax, Not set

Local Institution - 0035, Athens, Not set

Local Institution - 0036, Budapest, Not set

Local Institution - 0015, Ancona, Not set

Local Institution - 0012, Firenze, Not set

Local Institution - 0013, Genova, Not set

Local Institution - 0043, Ravenna, Not set

Local Institution - 0044, Terni, Not set

Local Institution - 0014, Torino, Not set

Local Institution - 0046, Aomori-shi, Aomori

Local Institution - 0047, Shibukawa-shi, Gunma

Local Institution - 0049, Osaka-shi, Osaka

Local Institution - 0048, Koto-ku, Tokyo

Local Institution - 0050, Chiba, Not set

Local Institution - 0045, Kasama-shi, Not set

Local Institution - 0027, Chorzow, Not set

Local Institution - 0026, Warszawa, Not set

Local Institution - 0039, Warszawa, Not set

Local Institution - 0028, Bucuresti, Not set

Local Institution - 0029, Iasi, Not set

Local Institution - 0041, Barcelona, Not set

Local Institution - 0030, Toledo, Not set

Local Institution - 0031, Cebeci Ankara, Not set

Local Institution - 0032, London, Not set

Conditions: Multiple Myeloma

Learn More ›

Comparing the Combination of Selinexor-Daratumumab-Velcade-Dexamethasone (Dara-SVD) With the Usual Treatment (Dara-RVD) for High-Risk Newly Diagnosed Multiple Myeloma

NCT06169215

Recruiting

This phase II trial compares the combination of selinexor, daratumumab, velcade (bortezomib), and dexamethasone (Dara-SVD) to the usual treatment of daratumumab, lenalidomide, bortezomib, and dexamethasone (Dara-RVD) in treating patients with high-risk newly diagnosed multiple myeloma. Selinexor is in a class of medications called selective inhibitors of nuclear export (SINE). It works by blocking a protein called CRM1, which may keep cancer cells from growing and may kill them. Daratumumab is i... Read More

Gender:

ALL

Ages:

All

Trial Updated:

06/03/2025

Locations: UCI Health - Chao Family Comprehensive Cancer Center and Ambulatory Care, Irvine, California +26 locations

UCI Health - Chao Family Comprehensive Cancer Center and Ambulatory Care, Irvine, California

UCI Health Laguna Hills, Laguna Hills, California

UC Irvine Health/Chao Family Comprehensive Cancer Center, Orange, California

University of California Davis Comprehensive Cancer Center, Sacramento, California

Smilow Cancer Hospital-Derby Care Center, Derby, Connecticut

Smilow Cancer Hospital Care Center-Fairfield, Fairfield, Connecticut

Smilow Cancer Hospital Care Center at Glastonbury, Glastonbury, Connecticut

Smilow Cancer Hospital Care Center at Greenwich, Greenwich, Connecticut

Smilow Cancer Hospital Care Center - Guilford, Guilford, Connecticut

Smilow Cancer Hospital Care Center at Saint Francis, Hartford, Connecticut

Smilow Cancer Center/Yale-New Haven Hospital, New Haven, Connecticut

Yale University, New Haven, Connecticut

Yale-New Haven Hospital North Haven Medical Center, North Haven, Connecticut

Smilow Cancer Hospital Care Center at Long Ridge, Stamford, Connecticut

Smilow Cancer Hospital-Torrington Care Center, Torrington, Connecticut

Smilow Cancer Hospital Care Center-Trumbull, Trumbull, Connecticut

Smilow Cancer Hospital-Waterbury Care Center, Waterbury, Connecticut

Smilow Cancer Hospital Care Center - Waterford, Waterford, Connecticut

Johns Hopkins University/Sidney Kimmel Cancer Center, Baltimore, Maryland

NYU Langone Hospital - Brooklyn, Brooklyn, New York

NYU Langone Hospital - Long Island, Mineola, New York

Laura and Isaac Perlmutter Cancer Center at NYU Langone, New York, New York

NYP/Weill Cornell Medical Center, New York, New York

Ohio State University Comprehensive Cancer Center, Columbus, Ohio

Smilow Cancer Hospital Care Center - Westerly, Westerly, Rhode Island

Vanderbilt University/Ingram Cancer Center, Nashville, Tennessee

Virginia Commonwealth University/Massey Cancer Center, Richmond, Virginia

Conditions: Multiple Myeloma

Learn More ›

PDS01ADC in Combination With Hepatic Artery Infusion Pump (HAIP) and Systemic Therapy for Subjects With Metastatic Colorectal Cancer, Intrahepatic Cholangiocarcinoma, or Metastatic Adrenocortical Carcinoma

NCT05286814

Recruiting

Background: One way to treat liver cancer is to deliver chemotherapy drugs only to the liver (and not to the whole body). Researchers want to see if adding the drug PDS01ADC can improve the treatment. The drug triggers the immune system to fight cancer.\ Objective: To see if treatment with HAIPs to deliver liver-directed chemotherapy in combination with PDS01ADC is effective for certain cancers. Eligibility: People aged 18 and older who have cancer of the bile ducts that is only in th... Read More

Gender:

ALL

Ages:

18 years and above

Trial Updated:

06/03/2025

Locations: National Institutes of Health Clinical Center, Bethesda, Maryland

Conditions: Metastatic Colorectal Cancer (Mcrc), Intrahepatic Cholangiocarcinoma (Icc), Colorectal Cancer, Colorectal Neoplasms, Cholangiocarcinoma, Intrahepatic Bile Duct Cancer, Bile Duct Cancer, Bile Duct Neoplasms

Learn More ›

Browse by State

Dexamethasone treatment options in Alabama

Dexamethasone treatment options in Alaska

Dexamethasone treatment options in Arizona

Dexamethasone treatment options in Arkansas

Dexamethasone treatment options in California

Dexamethasone treatment options in Colorado

Dexamethasone treatment options in Connecticut

Dexamethasone treatment options in Delaware

Dexamethasone treatment options in District of Columbia

Dexamethasone treatment options in Florida

Dexamethasone treatment options in Georgia

Dexamethasone treatment options in Hawaii

Dexamethasone treatment options in Idaho

Dexamethasone treatment options in Illinois

Dexamethasone treatment options in Indiana

Dexamethasone treatment options in Iowa

Dexamethasone treatment options in Kansas

Dexamethasone treatment options in Kentucky

Dexamethasone treatment options in Louisiana

Dexamethasone treatment options in Maine

Dexamethasone treatment options in Montana

Dexamethasone treatment options in Nebraska

Dexamethasone treatment options in Nevada

Dexamethasone treatment options in New Hampshire

Dexamethasone treatment options in New Jersey

Dexamethasone treatment options in New Mexico

Dexamethasone treatment options in New York

Dexamethasone treatment options in North Carolina

Dexamethasone treatment options in North Dakota

Dexamethasone treatment options in Ohio

Dexamethasone treatment options in Oklahoma

Dexamethasone treatment options in Oregon

Dexamethasone treatment options in Maryland

Dexamethasone treatment options in Massachusetts

Dexamethasone treatment options in Michigan

Dexamethasone treatment options in Minnesota

Dexamethasone treatment options in Mississippi

Dexamethasone treatment options in Missouri

Dexamethasone treatment options in Pennsylvania

Dexamethasone treatment options in Rhode Island

Dexamethasone treatment options in South Carolina

Dexamethasone treatment options in South Dakota

Dexamethasone treatment options in Tennessee

Dexamethasone treatment options in Texas

Dexamethasone treatment options in Utah

Dexamethasone treatment options in Vermont

Dexamethasone treatment options in Virginia

Dexamethasone treatment options in Washington

Dexamethasone treatment options in West Virginia

Dexamethasone treatment options in Wisconsin

Dexamethasone treatment options in Wyoming